Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc. (BBNX), sold 868 shares at $17.03 ($16K) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Open-market sale of $16k BBNX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.03 | 238 | $4K | 26.1% |
| 2 | $18.15 | 551 | $10K | 64.4% |
| 3 | $18.69 | 79 | $1K | 9.5% |
| Total | $17.89 avg | 868 | $16K | 100% |
| Filing → |
| BBNX | SELL | 2026-09-17 | $620K | — | Filing → |
| BBNX | SELL | 2026-09-15 | $12K | — | Filing → |
| BBNX | SELL | 2026-09-10 | $681K | — | Filing → |